Cargando…

Preclinical platforms to study therapeutic efficacy of human γδ T cells

BACKGROUND: Gamma delta (γδ) T lymphocytes are promising candidate for adoptive T cell therapy, however, their treatment efficacy is not satisfactory. Vδ2 T cells are unique to primates and few suitable models are available to assay their anti‐tumour function. METHODS: We tested human γδ T cell acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Lingling, Wang, Huaishan, Huang, Hui, Zhou, Zhiyan, Lin, Qiang, Guo, Yeye, Mitchell, Tara, Huang, Alexander C., Karakousis, Giorgos, Schuchter, Lynn, Amaravadi, Ravi, Guo, Wei, Salvino, Joseph, Herlyn, Meenhard, Xu, Xiaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217106/ https://www.ncbi.nlm.nih.gov/pubmed/35731974 http://dx.doi.org/10.1002/ctm2.814

Ejemplares similares

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies
por: Ou, Lingling, et al.
Publicado: (2023)

Dichotomous and stable gamma delta T-cell number and function in healthy individuals
por: Ou, Lingling, et al.
Publicado: (2021)

Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function
por: Wang, Huaishan, et al.
Publicado: (2021)

Small extracellular vesicles‐based cell‐free strategies for therapy
por: Guo, Yeye, et al.
Publicado: (2021)

Targeting regulatory T cells for immunotherapy in melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity
por: Zhong, Wenqun, et al.
Publicado: (2023)

HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8(+) T-cell infiltration into tumors
por: Guan, Lei, et al.
Publicado: (2022)

Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform
por: Schayowitz, Adam, et al.
Publicado: (2012)

Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy
por: Anstadt, Emily J, et al.
Publicado: (2022)

Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells
por: McLane, Laura M., et al.
Publicado: (2021)

Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer
por: Kwak, Taekyoung, et al.
Publicado: (2020)

Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma
por: Echevarría‐Vargas, Ileabett M, et al.
Publicado: (2018)

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
por: Liu, Shujing, et al.
Publicado: (2017)

Autophagy Paradox: Strategizing Treatment Modality in Melanoma
por: Pangilinan, Christian, et al.
Publicado: (2023)

Gene expression profiling of melanoma cells – searching the haystack
por: Brafford, Patricia, et al.
Publicado: (2005)

Narrowing the knowledge gaps for melanoma
por: Slipicevic, Ana, et al.
Publicado: (2012)

Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma
por: Bogenrieder, Thomas, et al.
Publicado: (2002)

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma
por: Mehnert, Janice M., et al.
Publicado: (2022)

TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion
por: Khan, Omar, et al.
Publicado: (2019)

PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
por: Lu, Hezhe, et al.
Publicado: (2017)

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance
por: Liu, Jianglan, et al.
Publicado: (2021)

TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination
por: Zhu, Guixin, et al.
Publicado: (2021)

Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response
por: Chen, Gang, et al.
Publicado: (2018)

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
por: Li, Ling, et al.
Publicado: (2011)

From cancer stem cells to tumor maintenance in melanoma
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2011)

Pre-clinical modeling of cutaneous melanoma
por: Rebecca, Vito W., et al.
Publicado: (2020)

Challenges in the humanized mouse model for cancer: A commentary
por: Ramirez-Salazar, Eric, et al.
Publicado: (2021)

A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes
por: Maity, Amit, et al.
Publicado: (2021)

γδ T cell exhaustion: Opportunities for intervention
por: Chen, Di, et al.
Publicado: (2022)

Matricellular Proteins Produced by Melanocytes and Melanomas: In Search for Functions
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2008)

The Case for Selective Use of Pre-Operative Chemotherapy for Hepatic Colorectal Metastases: More Is Not Always Better
por: Karakousis, Giorgos, et al.
Publicado: (2009)

Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
por: Maurer, Margarita, et al.
Publicado: (2012)

Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
por: Liu, Wei, et al.
Publicado: (2020)

γδ T Cells Provide Protective Function in Highly Pathogenic Avian H5N1 Influenza A Virus Infection
por: Dong, Peng, et al.
Publicado: (2018)

The macrophage: Switches from a passenger to a driver during anticancer therapy
por: Wang, Tao, et al.
Publicado: (2015)

Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3′ untranslated region of TRIT1
por: Swoboda, Rolf K, et al.
Publicado: (2015)

Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors
por: Yang, Ruifeng, et al.
Publicado: (2014)

Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
por: Bajor, David L., et al.
Publicado: (2018)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovn84dl0ntqn5b3lbp490dnnrm